Close
Nordic 9Nordic 9

i&i Biotech Fund (investor - Others)

Luxembourg inibio.eu
See something wrong or missing? Let us know
Offices:Luxembourg

i&i Biotech Fund is a Luxembourg-based tech transfer fund focused on Life Sciences.

Average round investment:9.52M USD
Average number per year:2.4
Distribution: 2026 (2)2025 (3)2024 (2)2023 (2)2022 (3)
Portfolio companies: United Kingdom Ternary TherapeuticsUnited Kingdom AntiverseGermany T-curx See the entire list
Mostly invests in: United Kingdom United Kingdom (3) Biotech (10)
See the entire list

Showing 3 of 12 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to i&i Biotech Fund

Name Criteria
Germany Magnetic VC
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Netherlands
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
France Ovni Capital
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data), Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United Kingdom Paul Graham
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data), Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom Founders Capital UK
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Denmark Florent Venture Partners
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Portugal HCapital
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Austria xista science venture
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data), Pharma, Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Austria
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United States Cal Henderson
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data), Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Germany WestTech Ventures
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing, AI (big data), Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Spain Moira Capital Partners
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Top